uniQure NV (QURE)
5.78
-0.06
(-1.11%)
USD |
NASDAQ |
Nov 22, 16:00
5.775
0.00 (0.00%)
Pre-Market: 20:00
uniQure Debt to Equity Ratio: 0.9157 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.9157 |
| June 30, 2024 | 1.056 |
| March 31, 2024 | 0.6959 |
| December 31, 2023 | 0.49 |
| September 30, 2023 | 0.3774 |
| June 30, 2023 | 0.2862 |
| March 31, 2023 | 0.2501 |
| December 31, 2022 | 0.2159 |
| September 30, 2022 | 0.2431 |
| June 30, 2022 | 0.2094 |
| March 31, 2022 | 0.1858 |
| December 31, 2021 | 0.1695 |
| September 30, 2021 | 0.121 |
| June 30, 2021 | 0.1117 |
| March 31, 2021 | 0.3081 |
| December 31, 2020 | 0.146 |
| September 30, 2020 | 0.1557 |
| June 30, 2020 | 0.1332 |
| March 31, 2020 | 0.1227 |
| December 31, 2019 | 0.1116 |
| September 30, 2019 | 0.1026 |
| June 30, 2019 | 0.271 |
| March 31, 2019 | 0.2268 |
| Date | Value |
|---|---|
| December 31, 2018 | 0.1975 |
| September 30, 2018 | 0.1036 |
| June 30, 2018 | 0.0955 |
| March 31, 2018 | 0.2076 |
| December 31, 2017 | 0.2327 |
| September 30, 2017 | 1.050 |
| June 30, 2017 | 0.7503 |
| March 31, 2017 | 0.4453 |
| December 31, 2016 | 0.318 |
| September 30, 2016 | 0.2609 |
| June 30, 2016 | 0.2227 |
| March 31, 2016 | 0.1831 |
| December 31, 2015 | 0.158 |
| September 30, 2015 | 0.1445 |
| June 30, 2015 | 0.1634 |
| March 31, 2015 | 0.577 |
| December 31, 2014 | 0.3969 |
| September 30, 2014 | 0.3169 |
| June 30, 2014 | 0.2652 |
| March 31, 2014 | 0.1158 |
| December 31, 2013 | 1.284 |
| September 30, 2013 | 0.6681 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.1116
Minimum
Dec 2019
1.056
Maximum
Jun 2024
0.3152
Average
0.2127
Median
Debt to Equity Ratio Benchmarks
| ProQR Therapeutics NV | 0.1805 |
| Merus NV | 0.00 |
| argenx SE | -- |
| Pharming Group | 0.4226 |
| Pharvaris NV | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 645.81M |
| Total Liabilities (Quarterly) | 589.98M |
| Shareholders Equity (Quarterly) | 55.82M |
| Current Ratio | 6.512 |
| Net Debt Paydown Yield | 4.16% |